nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—Dactinomycin—testicular cancer	0.0967	0.163	CbGbCtD
Fesoterodine—CYP3A4—Ifosfamide—testicular cancer	0.0684	0.115	CbGbCtD
Fesoterodine—ABCB1—Vinblastine—testicular cancer	0.0606	0.102	CbGbCtD
Fesoterodine—CYP2D6—Vinblastine—testicular cancer	0.0571	0.0963	CbGbCtD
Fesoterodine—ABCB1—Cisplatin—testicular cancer	0.0555	0.0937	CbGbCtD
Fesoterodine—ABCB1—Etoposide—testicular cancer	0.0546	0.0921	CbGbCtD
Fesoterodine—ABCB1—Doxorubicin—testicular cancer	0.0372	0.0628	CbGbCtD
Fesoterodine—CYP3A4—Vinblastine—testicular cancer	0.0363	0.0613	CbGbCtD
Fesoterodine—ABCB1—Methotrexate—testicular cancer	0.0361	0.0609	CbGbCtD
Fesoterodine—CYP2D6—Doxorubicin—testicular cancer	0.0351	0.0592	CbGbCtD
Fesoterodine—CYP3A4—Etoposide—testicular cancer	0.0327	0.0552	CbGbCtD
Fesoterodine—CYP3A4—Doxorubicin—testicular cancer	0.0223	0.0376	CbGbCtD
Fesoterodine—Angioedema—Ifosfamide—testicular cancer	0.00135	0.00332	CcSEcCtD
Fesoterodine—Hypersensitivity—Chlorambucil—testicular cancer	0.00135	0.0033	CcSEcCtD
Fesoterodine—Vertigo—Ifosfamide—testicular cancer	0.00133	0.00327	CcSEcCtD
Fesoterodine—Urinary tract disorder—Etoposide—testicular cancer	0.00133	0.00326	CcSEcCtD
Fesoterodine—Abdominal pain—Vinblastine—testicular cancer	0.00132	0.00325	CcSEcCtD
Fesoterodine—Mediastinal disorder—Cisplatin—testicular cancer	0.00132	0.00324	CcSEcCtD
Fesoterodine—Urethral disorder—Etoposide—testicular cancer	0.00132	0.00323	CcSEcCtD
Fesoterodine—Asthenia—Chlorambucil—testicular cancer	0.00131	0.00322	CcSEcCtD
Fesoterodine—Infection—Dactinomycin—testicular cancer	0.00131	0.00322	CcSEcCtD
Fesoterodine—Palpitations—Ifosfamide—testicular cancer	0.00131	0.00321	CcSEcCtD
Fesoterodine—Pruritus—Chlorambucil—testicular cancer	0.00129	0.00317	CcSEcCtD
Fesoterodine—Cough—Ifosfamide—testicular cancer	0.00129	0.00317	CcSEcCtD
Fesoterodine—Dry eye—Doxorubicin—testicular cancer	0.00128	0.00315	CcSEcCtD
Fesoterodine—Chest pain—Ifosfamide—testicular cancer	0.00126	0.00309	CcSEcCtD
Fesoterodine—Flatulence—Cisplatin—testicular cancer	0.00126	0.00309	CcSEcCtD
Fesoterodine—Eye disorder—Etoposide—testicular cancer	0.00126	0.00308	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00125	0.00307	CcSEcCtD
Fesoterodine—Diarrhoea—Chlorambucil—testicular cancer	0.00125	0.00307	CcSEcCtD
Fesoterodine—Cardiac disorder—Etoposide—testicular cancer	0.00125	0.00306	CcSEcCtD
Fesoterodine—Hypersensitivity—Vinblastine—testicular cancer	0.00123	0.00303	CcSEcCtD
Fesoterodine—Confusional state—Ifosfamide—testicular cancer	0.00122	0.00299	CcSEcCtD
Fesoterodine—Mediastinal disorder—Etoposide—testicular cancer	0.00121	0.00297	CcSEcCtD
Fesoterodine—Vision blurred—Cisplatin—testicular cancer	0.0012	0.00295	CcSEcCtD
Fesoterodine—Asthenia—Vinblastine—testicular cancer	0.0012	0.00295	CcSEcCtD
Fesoterodine—Infection—Ifosfamide—testicular cancer	0.0012	0.00295	CcSEcCtD
Fesoterodine—Nervous system disorder—Ifosfamide—testicular cancer	0.00119	0.00291	CcSEcCtD
Fesoterodine—Skin disorder—Ifosfamide—testicular cancer	0.00117	0.00288	CcSEcCtD
Fesoterodine—Feeling abnormal—Bleomycin—testicular cancer	0.00117	0.00286	CcSEcCtD
Fesoterodine—Diarrhoea—Vinblastine—testicular cancer	0.00115	0.00281	CcSEcCtD
Fesoterodine—Dysgeusia—Etoposide—testicular cancer	0.00115	0.00281	CcSEcCtD
Fesoterodine—Fatigue—Dactinomycin—testicular cancer	0.00114	0.00279	CcSEcCtD
Fesoterodine—Back pain—Etoposide—testicular cancer	0.00113	0.00278	CcSEcCtD
Fesoterodine—Urticaria—Bleomycin—testicular cancer	0.00112	0.00276	CcSEcCtD
Fesoterodine—Dizziness—Vinblastine—testicular cancer	0.00111	0.00272	CcSEcCtD
Fesoterodine—Feeling abnormal—Dactinomycin—testicular cancer	0.00109	0.00267	CcSEcCtD
Fesoterodine—Nausea—Chlorambucil—testicular cancer	0.00109	0.00266	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00108	0.00265	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00108	0.00265	CcSEcCtD
Fesoterodine—Somnolence—Ifosfamide—testicular cancer	0.00107	0.00264	CcSEcCtD
Fesoterodine—Face oedema—Epirubicin—testicular cancer	0.00105	0.00258	CcSEcCtD
Fesoterodine—Vertigo—Etoposide—testicular cancer	0.00105	0.00258	CcSEcCtD
Fesoterodine—Headache—Vinblastine—testicular cancer	0.00105	0.00258	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00104	0.00256	CcSEcCtD
Fesoterodine—Abdominal pain—Dactinomycin—testicular cancer	0.00104	0.00256	CcSEcCtD
Fesoterodine—Fatigue—Ifosfamide—testicular cancer	0.00104	0.00256	CcSEcCtD
Fesoterodine—Hypersensitivity—Bleomycin—testicular cancer	0.00104	0.00256	CcSEcCtD
Fesoterodine—Infection—Cisplatin—testicular cancer	0.00104	0.00254	CcSEcCtD
Fesoterodine—Constipation—Ifosfamide—testicular cancer	0.00103	0.00254	CcSEcCtD
Fesoterodine—Nervous system disorder—Cisplatin—testicular cancer	0.00102	0.00251	CcSEcCtD
Fesoterodine—Cough—Etoposide—testicular cancer	0.00102	0.00251	CcSEcCtD
Fesoterodine—Tachycardia—Cisplatin—testicular cancer	0.00102	0.0025	CcSEcCtD
Fesoterodine—Asthenia—Bleomycin—testicular cancer	0.00101	0.00249	CcSEcCtD
Fesoterodine—Skin disorder—Cisplatin—testicular cancer	0.00101	0.00248	CcSEcCtD
Fesoterodine—Pruritus—Bleomycin—testicular cancer	0.001	0.00246	CcSEcCtD
Fesoterodine—Dry skin—Epirubicin—testicular cancer	0.000998	0.00245	CcSEcCtD
Fesoterodine—Feeling abnormal—Ifosfamide—testicular cancer	0.000996	0.00244	CcSEcCtD
Fesoterodine—Chest pain—Etoposide—testicular cancer	0.000996	0.00244	CcSEcCtD
Fesoterodine—Nausea—Vinblastine—testicular cancer	0.000995	0.00244	CcSEcCtD
Fesoterodine—Abdominal pain upper—Epirubicin—testicular cancer	0.000995	0.00244	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000989	0.00243	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000989	0.00243	CcSEcCtD
Fesoterodine—Face oedema—Doxorubicin—testicular cancer	0.000973	0.00239	CcSEcCtD
Fesoterodine—Hypersensitivity—Dactinomycin—testicular cancer	0.000972	0.00239	CcSEcCtD
Fesoterodine—Abdominal discomfort—Methotrexate—testicular cancer	0.000964	0.00237	CcSEcCtD
Fesoterodine—Confusional state—Etoposide—testicular cancer	0.000963	0.00236	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00096	0.00236	CcSEcCtD
Fesoterodine—Urticaria—Ifosfamide—testicular cancer	0.00096	0.00236	CcSEcCtD
Fesoterodine—Abdominal pain—Ifosfamide—testicular cancer	0.000956	0.00235	CcSEcCtD
Fesoterodine—Infection—Etoposide—testicular cancer	0.000949	0.00233	CcSEcCtD
Fesoterodine—Asthenia—Dactinomycin—testicular cancer	0.000947	0.00232	CcSEcCtD
Fesoterodine—Dysuria—Methotrexate—testicular cancer	0.00094	0.00231	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000935	0.00229	CcSEcCtD
Fesoterodine—Tachycardia—Etoposide—testicular cancer	0.000932	0.00229	CcSEcCtD
Fesoterodine—Skin disorder—Etoposide—testicular cancer	0.000927	0.00228	CcSEcCtD
Fesoterodine—Dry skin—Doxorubicin—testicular cancer	0.000924	0.00227	CcSEcCtD
Fesoterodine—Abdominal pain upper—Doxorubicin—testicular cancer	0.00092	0.00226	CcSEcCtD
Fesoterodine—Angina pectoris—Epirubicin—testicular cancer	0.000917	0.00225	CcSEcCtD
Fesoterodine—Diarrhoea—Dactinomycin—testicular cancer	0.000903	0.00222	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0009	0.00221	CcSEcCtD
Fesoterodine—Infestation NOS—Methotrexate—testicular cancer	0.000897	0.0022	CcSEcCtD
Fesoterodine—Infestation—Methotrexate—testicular cancer	0.000897	0.0022	CcSEcCtD
Fesoterodine—Rash—Bleomycin—testicular cancer	0.000892	0.00219	CcSEcCtD
Fesoterodine—Dermatitis—Bleomycin—testicular cancer	0.000891	0.00219	CcSEcCtD
Fesoterodine—Hypersensitivity—Ifosfamide—testicular cancer	0.000891	0.00219	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000889	0.00218	CcSEcCtD
Fesoterodine—Dysuria—Epirubicin—testicular cancer	0.00088	0.00216	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000875	0.00215	CcSEcCtD
Fesoterodine—Asthenia—Ifosfamide—testicular cancer	0.000867	0.00213	CcSEcCtD
Fesoterodine—Feeling abnormal—Cisplatin—testicular cancer	0.000859	0.00211	CcSEcCtD
Fesoterodine—Pruritus—Ifosfamide—testicular cancer	0.000855	0.0021	CcSEcCtD
Fesoterodine—Somnolence—Etoposide—testicular cancer	0.000849	0.00208	CcSEcCtD
Fesoterodine—Angina pectoris—Doxorubicin—testicular cancer	0.000848	0.00208	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000848	0.00208	CcSEcCtD
Fesoterodine—Nausea—Bleomycin—testicular cancer	0.00084	0.00206	CcSEcCtD
Fesoterodine—Infestation NOS—Epirubicin—testicular cancer	0.000839	0.00206	CcSEcCtD
Fesoterodine—Infestation—Epirubicin—testicular cancer	0.000839	0.00206	CcSEcCtD
Fesoterodine—Rash—Dactinomycin—testicular cancer	0.000832	0.00204	CcSEcCtD
Fesoterodine—Diarrhoea—Ifosfamide—testicular cancer	0.000827	0.00203	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000824	0.00202	CcSEcCtD
Fesoterodine—Fatigue—Etoposide—testicular cancer	0.000823	0.00202	CcSEcCtD
Fesoterodine—Constipation—Etoposide—testicular cancer	0.000817	0.002	CcSEcCtD
Fesoterodine—Urinary tract infection—Epirubicin—testicular cancer	0.000816	0.002	CcSEcCtD
Fesoterodine—Dysuria—Doxorubicin—testicular cancer	0.000814	0.002	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000809	0.00199	CcSEcCtD
Fesoterodine—Dizziness—Ifosfamide—testicular cancer	0.000799	0.00196	CcSEcCtD
Fesoterodine—Urinary tract disorder—Methotrexate—testicular cancer	0.000795	0.00195	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000794	0.00195	CcSEcCtD
Fesoterodine—Urethral disorder—Methotrexate—testicular cancer	0.000789	0.00194	CcSEcCtD
Fesoterodine—Feeling abnormal—Etoposide—testicular cancer	0.000787	0.00193	CcSEcCtD
Fesoterodine—Nausea—Dactinomycin—testicular cancer	0.000784	0.00192	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Etoposide—testicular cancer	0.000781	0.00192	CcSEcCtD
Fesoterodine—Infestation NOS—Doxorubicin—testicular cancer	0.000777	0.00191	CcSEcCtD
Fesoterodine—Infestation—Doxorubicin—testicular cancer	0.000777	0.00191	CcSEcCtD
Fesoterodine—Hypersensitivity—Cisplatin—testicular cancer	0.000768	0.00188	CcSEcCtD
Fesoterodine—Rash—Ifosfamide—testicular cancer	0.000762	0.00187	CcSEcCtD
Fesoterodine—Dermatitis—Ifosfamide—testicular cancer	0.000762	0.00187	CcSEcCtD
Fesoterodine—Urticaria—Etoposide—testicular cancer	0.000759	0.00186	CcSEcCtD
Fesoterodine—Abdominal pain—Etoposide—testicular cancer	0.000755	0.00185	CcSEcCtD
Fesoterodine—Urinary tract infection—Doxorubicin—testicular cancer	0.000755	0.00185	CcSEcCtD
Fesoterodine—Eye disorder—Methotrexate—testicular cancer	0.000752	0.00185	CcSEcCtD
Fesoterodine—Asthenia—Cisplatin—testicular cancer	0.000748	0.00184	CcSEcCtD
Fesoterodine—Cardiac disorder—Methotrexate—testicular cancer	0.000747	0.00183	CcSEcCtD
Fesoterodine—Urinary tract disorder—Epirubicin—testicular cancer	0.000744	0.00183	CcSEcCtD
Fesoterodine—Oedema peripheral—Epirubicin—testicular cancer	0.000742	0.00182	CcSEcCtD
Fesoterodine—Urethral disorder—Epirubicin—testicular cancer	0.000739	0.00181	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000734	0.0018	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methotrexate—testicular cancer	0.000726	0.00178	CcSEcCtD
Fesoterodine—Nausea—Ifosfamide—testicular cancer	0.000718	0.00176	CcSEcCtD
Fesoterodine—Diarrhoea—Cisplatin—testicular cancer	0.000713	0.00175	CcSEcCtD
Fesoterodine—Mental disorder—Methotrexate—testicular cancer	0.000705	0.00173	CcSEcCtD
Fesoterodine—Eye disorder—Epirubicin—testicular cancer	0.000704	0.00173	CcSEcCtD
Fesoterodine—Hypersensitivity—Etoposide—testicular cancer	0.000704	0.00173	CcSEcCtD
Fesoterodine—Cardiac disorder—Epirubicin—testicular cancer	0.000699	0.00172	CcSEcCtD
Fesoterodine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000688	0.00169	CcSEcCtD
Fesoterodine—Oedema peripheral—Doxorubicin—testicular cancer	0.000687	0.00169	CcSEcCtD
Fesoterodine—Dysgeusia—Methotrexate—testicular cancer	0.000686	0.00168	CcSEcCtD
Fesoterodine—Asthenia—Etoposide—testicular cancer	0.000685	0.00168	CcSEcCtD
Fesoterodine—Urethral disorder—Doxorubicin—testicular cancer	0.000683	0.00168	CcSEcCtD
Fesoterodine—Mediastinal disorder—Epirubicin—testicular cancer	0.000679	0.00167	CcSEcCtD
Fesoterodine—Back pain—Methotrexate—testicular cancer	0.000678	0.00166	CcSEcCtD
Fesoterodine—Pruritus—Etoposide—testicular cancer	0.000676	0.00166	CcSEcCtD
Fesoterodine—Vision blurred—Methotrexate—testicular cancer	0.00066	0.00162	CcSEcCtD
Fesoterodine—Mental disorder—Epirubicin—testicular cancer	0.00066	0.00162	CcSEcCtD
Fesoterodine—Rash—Cisplatin—testicular cancer	0.000657	0.00161	CcSEcCtD
Fesoterodine—Dermatitis—Cisplatin—testicular cancer	0.000657	0.00161	CcSEcCtD
Fesoterodine—Diarrhoea—Etoposide—testicular cancer	0.000653	0.0016	CcSEcCtD
Fesoterodine—Eye disorder—Doxorubicin—testicular cancer	0.000651	0.0016	CcSEcCtD
Fesoterodine—Cardiac disorder—Doxorubicin—testicular cancer	0.000647	0.00159	CcSEcCtD
Fesoterodine—Flatulence—Epirubicin—testicular cancer	0.000646	0.00159	CcSEcCtD
Fesoterodine—Dysgeusia—Epirubicin—testicular cancer	0.000642	0.00158	CcSEcCtD
Fesoterodine—Back pain—Epirubicin—testicular cancer	0.000634	0.00156	CcSEcCtD
Fesoterodine—Dizziness—Etoposide—testicular cancer	0.000631	0.00155	CcSEcCtD
Fesoterodine—Vertigo—Methotrexate—testicular cancer	0.00063	0.00155	CcSEcCtD
Fesoterodine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000628	0.00154	CcSEcCtD
Fesoterodine—Nausea—Cisplatin—testicular cancer	0.000619	0.00152	CcSEcCtD
Fesoterodine—Vision blurred—Epirubicin—testicular cancer	0.000618	0.00152	CcSEcCtD
Fesoterodine—Cough—Methotrexate—testicular cancer	0.000612	0.0015	CcSEcCtD
Fesoterodine—Mental disorder—Doxorubicin—testicular cancer	0.000611	0.0015	CcSEcCtD
Fesoterodine—Rash—Etoposide—testicular cancer	0.000602	0.00148	CcSEcCtD
Fesoterodine—Dermatitis—Etoposide—testicular cancer	0.000602	0.00148	CcSEcCtD
Fesoterodine—Headache—Etoposide—testicular cancer	0.000598	0.00147	CcSEcCtD
Fesoterodine—Flatulence—Doxorubicin—testicular cancer	0.000598	0.00147	CcSEcCtD
Fesoterodine—Chest pain—Methotrexate—testicular cancer	0.000597	0.00146	CcSEcCtD
Fesoterodine—Dysgeusia—Doxorubicin—testicular cancer	0.000594	0.00146	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000593	0.00145	CcSEcCtD
Fesoterodine—Vertigo—Epirubicin—testicular cancer	0.000589	0.00145	CcSEcCtD
Fesoterodine—Back pain—Doxorubicin—testicular cancer	0.000587	0.00144	CcSEcCtD
Fesoterodine—Palpitations—Epirubicin—testicular cancer	0.00058	0.00142	CcSEcCtD
Fesoterodine—Confusional state—Methotrexate—testicular cancer	0.000577	0.00142	CcSEcCtD
Fesoterodine—Cough—Epirubicin—testicular cancer	0.000572	0.0014	CcSEcCtD
Fesoterodine—Vision blurred—Doxorubicin—testicular cancer	0.000572	0.0014	CcSEcCtD
Fesoterodine—Infection—Methotrexate—testicular cancer	0.000568	0.00139	CcSEcCtD
Fesoterodine—Nausea—Etoposide—testicular cancer	0.000567	0.00139	CcSEcCtD
Fesoterodine—Nervous system disorder—Methotrexate—testicular cancer	0.000561	0.00138	CcSEcCtD
Fesoterodine—Chest pain—Epirubicin—testicular cancer	0.000558	0.00137	CcSEcCtD
Fesoterodine—Skin disorder—Methotrexate—testicular cancer	0.000556	0.00136	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000555	0.00136	CcSEcCtD
Fesoterodine—Dry mouth—Epirubicin—testicular cancer	0.000546	0.00134	CcSEcCtD
Fesoterodine—Vertigo—Doxorubicin—testicular cancer	0.000545	0.00134	CcSEcCtD
Fesoterodine—Confusional state—Epirubicin—testicular cancer	0.00054	0.00132	CcSEcCtD
Fesoterodine—Palpitations—Doxorubicin—testicular cancer	0.000536	0.00132	CcSEcCtD
Fesoterodine—Infection—Epirubicin—testicular cancer	0.000532	0.0013	CcSEcCtD
Fesoterodine—Cough—Doxorubicin—testicular cancer	0.00053	0.0013	CcSEcCtD
Fesoterodine—Nervous system disorder—Epirubicin—testicular cancer	0.000525	0.00129	CcSEcCtD
Fesoterodine—Tachycardia—Epirubicin—testicular cancer	0.000522	0.00128	CcSEcCtD
Fesoterodine—Skin disorder—Epirubicin—testicular cancer	0.00052	0.00128	CcSEcCtD
Fesoterodine—Insomnia—Methotrexate—testicular cancer	0.000517	0.00127	CcSEcCtD
Fesoterodine—Chest pain—Doxorubicin—testicular cancer	0.000517	0.00127	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000513	0.00126	CcSEcCtD
Fesoterodine—Somnolence—Methotrexate—testicular cancer	0.000508	0.00125	CcSEcCtD
Fesoterodine—Dry mouth—Doxorubicin—testicular cancer	0.000505	0.00124	CcSEcCtD
Fesoterodine—Dyspepsia—Methotrexate—testicular cancer	0.000503	0.00124	CcSEcCtD
Fesoterodine—Confusional state—Doxorubicin—testicular cancer	0.000499	0.00123	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000494	0.00121	CcSEcCtD
Fesoterodine—Fatigue—Methotrexate—testicular cancer	0.000493	0.00121	CcSEcCtD
Fesoterodine—Infection—Doxorubicin—testicular cancer	0.000492	0.00121	CcSEcCtD
Fesoterodine—Nervous system disorder—Doxorubicin—testicular cancer	0.000486	0.00119	CcSEcCtD
Fesoterodine—Insomnia—Epirubicin—testicular cancer	0.000484	0.00119	CcSEcCtD
Fesoterodine—Tachycardia—Doxorubicin—testicular cancer	0.000483	0.00119	CcSEcCtD
Fesoterodine—Skin disorder—Doxorubicin—testicular cancer	0.000481	0.00118	CcSEcCtD
Fesoterodine—Somnolence—Epirubicin—testicular cancer	0.000476	0.00117	CcSEcCtD
Fesoterodine—Feeling abnormal—Methotrexate—testicular cancer	0.000471	0.00116	CcSEcCtD
Fesoterodine—Dyspepsia—Epirubicin—testicular cancer	0.000471	0.00116	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000468	0.00115	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000462	0.00113	CcSEcCtD
Fesoterodine—Fatigue—Epirubicin—testicular cancer	0.000461	0.00113	CcSEcCtD
Fesoterodine—Constipation—Epirubicin—testicular cancer	0.000458	0.00112	CcSEcCtD
Fesoterodine—Urticaria—Methotrexate—testicular cancer	0.000454	0.00112	CcSEcCtD
Fesoterodine—Abdominal pain—Methotrexate—testicular cancer	0.000452	0.00111	CcSEcCtD
Fesoterodine—Insomnia—Doxorubicin—testicular cancer	0.000448	0.0011	CcSEcCtD
Fesoterodine—Feeling abnormal—Epirubicin—testicular cancer	0.000441	0.00108	CcSEcCtD
Fesoterodine—Somnolence—Doxorubicin—testicular cancer	0.00044	0.00108	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000438	0.00107	CcSEcCtD
Fesoterodine—Dyspepsia—Doxorubicin—testicular cancer	0.000436	0.00107	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000428	0.00105	CcSEcCtD
Fesoterodine—Fatigue—Doxorubicin—testicular cancer	0.000427	0.00105	CcSEcCtD
Fesoterodine—Urticaria—Epirubicin—testicular cancer	0.000425	0.00104	CcSEcCtD
Fesoterodine—Constipation—Doxorubicin—testicular cancer	0.000424	0.00104	CcSEcCtD
Fesoterodine—Abdominal pain—Epirubicin—testicular cancer	0.000423	0.00104	CcSEcCtD
Fesoterodine—Hypersensitivity—Methotrexate—testicular cancer	0.000421	0.00103	CcSEcCtD
Fesoterodine—Asthenia—Methotrexate—testicular cancer	0.00041	0.00101	CcSEcCtD
Fesoterodine—Feeling abnormal—Doxorubicin—testicular cancer	0.000408	0.001	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000405	0.000994	CcSEcCtD
Fesoterodine—Pruritus—Methotrexate—testicular cancer	0.000405	0.000993	CcSEcCtD
Fesoterodine—Hypersensitivity—Epirubicin—testicular cancer	0.000394	0.000968	CcSEcCtD
Fesoterodine—Urticaria—Doxorubicin—testicular cancer	0.000393	0.000966	CcSEcCtD
Fesoterodine—Abdominal pain—Doxorubicin—testicular cancer	0.000392	0.000961	CcSEcCtD
Fesoterodine—Diarrhoea—Methotrexate—testicular cancer	0.000391	0.00096	CcSEcCtD
Fesoterodine—Asthenia—Epirubicin—testicular cancer	0.000384	0.000942	CcSEcCtD
Fesoterodine—Pruritus—Epirubicin—testicular cancer	0.000379	0.000929	CcSEcCtD
Fesoterodine—Dizziness—Methotrexate—testicular cancer	0.000378	0.000928	CcSEcCtD
Fesoterodine—Diarrhoea—Epirubicin—testicular cancer	0.000366	0.000899	CcSEcCtD
Fesoterodine—Hypersensitivity—Doxorubicin—testicular cancer	0.000365	0.000895	CcSEcCtD
Fesoterodine—Rash—Methotrexate—testicular cancer	0.000361	0.000885	CcSEcCtD
Fesoterodine—Dermatitis—Methotrexate—testicular cancer	0.00036	0.000884	CcSEcCtD
Fesoterodine—Headache—Methotrexate—testicular cancer	0.000358	0.000879	CcSEcCtD
Fesoterodine—Asthenia—Doxorubicin—testicular cancer	0.000355	0.000872	CcSEcCtD
Fesoterodine—Dizziness—Epirubicin—testicular cancer	0.000354	0.000869	CcSEcCtD
Fesoterodine—Pruritus—Doxorubicin—testicular cancer	0.00035	0.00086	CcSEcCtD
Fesoterodine—Nausea—Methotrexate—testicular cancer	0.00034	0.000834	CcSEcCtD
Fesoterodine—Diarrhoea—Doxorubicin—testicular cancer	0.000339	0.000832	CcSEcCtD
Fesoterodine—Rash—Epirubicin—testicular cancer	0.000337	0.000828	CcSEcCtD
Fesoterodine—Dermatitis—Epirubicin—testicular cancer	0.000337	0.000827	CcSEcCtD
Fesoterodine—Headache—Epirubicin—testicular cancer	0.000335	0.000823	CcSEcCtD
Fesoterodine—Dizziness—Doxorubicin—testicular cancer	0.000328	0.000804	CcSEcCtD
Fesoterodine—Nausea—Epirubicin—testicular cancer	0.000318	0.00078	CcSEcCtD
Fesoterodine—Rash—Doxorubicin—testicular cancer	0.000312	0.000766	CcSEcCtD
Fesoterodine—Dermatitis—Doxorubicin—testicular cancer	0.000312	0.000766	CcSEcCtD
Fesoterodine—Headache—Doxorubicin—testicular cancer	0.00031	0.000761	CcSEcCtD
Fesoterodine—Nausea—Doxorubicin—testicular cancer	0.000294	0.000722	CcSEcCtD
